Single Subcutaneous Dose Of Regeneron’s Antibody Treatment Prevents COVID-19, Reduces Incidence Of Asymptomatic COVID-19 Infection, Study Finds

Healio (8/4, Downey) reports, “A single subcutaneous dose of Regeneron’s antibody cocktail prevents symptomatic COVID-19 and reduces the incidence of asymptomatic SARS-CoV-2 infection, according to results from a study published today in The New England J...